HI Jeff,

I listened to last night’s Sub Pro call (which I was unable to attend).  In that call, you advised the Sub Pro Working Group verbally that the independent contractor for NCAP Study 1, Karen Scarfone, had made a Study 1 recommendation against proceeding to Study 2 and 3.  You also stated that “not everyone” in the NCAP Discussion Group agrees with Karen’s recommendation that Study 2 and 3 should not proceed.

 

I can’t quite figure out why you believe that Karen made such a recommendation.  It would be good if you could clarify this before the April 30 call on Name Collisions.  Please reply to all.

 

Thank you,

Anne

 

 

From: NCAP-Discuss <ncap-discuss-bounces@icann.org> On Behalf Of Jeff Neuman
Sent: Monday, April 27, 2020 8:59 AM
To: Matt Larson <matt.larson@icann.org>
Cc: ncap-discuss@icann.org
Subject: Re: [NCAP-Discuss] [Ext] Re: Draft final Study 1 report

 

[EXTERNAL]


Thanks Matt.  I forwarded to the SubPro Group your original e-mail which contained the study and your cover note.

 

Jeff Neuman

Senior Vice President 

Com Laude | Valideus

D: +1.703.635.7514

E: jeff.neuman@comlaude.com

 

From: Matt Larson <matt.larson@icann.org>
Sent: Monday, April 27, 2020 11:29 AM
To: Jeff Neuman <jeff.neuman@comlaude.com>
Cc: ncap-discuss@icann.org
Subject: Re: [NCAP-Discuss] [Ext] Re: Draft final Study 1 report

 

Hi, Jeff, everyone.

 

On Apr 27, 2020, at 8:01 AM, Jeff Neuman <jeff.neuman@comlaude.com> wrote:

 

The SubPro Working Group is discussing the issue of Name Collisions on its Thursday call.  Is this list public?  And if so, can I post the latest document to the SubPro list so that they can see the current state of the studies?  I would be happy to post other comments you all have to the report as well that you would want shared.

 

This list has public archives, so anyone can see my message with the current draft attached. If you want to share on the SubPro list, could I please suggest that you point people to my message in the archives rather than send the document itself? That link is https://mm.icann.org/pipermail/ncap-discuss/2020-April/000275.html. Sharing the document that way will hopefully help keep the context clear, specifically, that this report is not final.

 

Matt

 


The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that the Com Laude Group does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 06181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176, having its registered office at 33 Melville Street, Edinburgh, Lothian, EH3 7JF Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, headquartered at 1751 Pinnacle Drive, Suite 600, McLean, VA 22102, USA; Com Laude (Japan) Corporation, a company registered in Japan having its registered office at Suite 319,1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan. For further information see www.comlaude.com




This message and any attachments are intended only for the use of the individual or entity to which they are addressed. If the reader of this message or an attachment is not the intended recipient or the employee or agent responsible for delivering the message or attachment to the intended recipient you are hereby notified that any dissemination, distribution or copying of this message or any attachment is strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the sender. The information transmitted in this message and any attachments may be privileged, is intended only for the personal and confidential use of the intended recipients, and is covered by the Electronic Communications Privacy Act, 18 U.S.C. §2510-2521.